Ultrasound-based Breast Cancer Screening in Chinese Women

NCT ID: NCT02268643

Last Updated: 2014-10-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the present study, the investigators will screen breast cancer of the Chinese women based on ultrasound and aim to compare the risk evaluation model of PUMCH model which was established by our previous work with other risk models.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Early detection of breast cancer through screening has been a common practice in the United States and several European countries for decades. It is effective in reducing the mortality of breast cancer and improving the postoperative quality of life of patients. Mammography has been the standard imaging method for the screening, however, our previous study has shown that ultrasound is more sensitive and less expensive than mammography. In the present study, the investigators will screen breast cancer of the Chinese women based on ultrasound and aim to evaluate the risk model (PUMCH model) which was established by our previous work.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group 1

ultrasound plus clinical breast examination

ultrasound plus clinical breast examination

Intervention Type OTHER

all the participants will be required to fill risk factor questionaires and then be screened with ultrasound plus physical examination every year

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasound plus clinical breast examination

all the participants will be required to fill risk factor questionaires and then be screened with ultrasound plus physical examination every year

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent;
* residence from community or working units

Exclusion Criteria

* pregnancy;
* lactation;
* known metastatic cancer;
* signs or symptoms of breast disease;
* presence of breast implants, breast surgery within prior 12 months;
* had mammography or ultrasound exam within prior 12 months
* males.
Minimum Eligible Age

35 Years

Maximum Eligible Age

75 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking Union Medical College Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qiang SUN

Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sun Qiang, MD

Role: STUDY_CHAIR

PUMCH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Beijing ChaoYang Hospital affiliated to the Capital Medical University

Beijing, Beijing Municipality, China

Site Status RECRUITING

Beijing Hospital affiliated to Ministry of Health

Beijing, Beijing Municipality, China

Site Status RECRUITING

First Hospital affiliated to Peking University

Beijing, Beijing Municipality, China

Site Status RECRUITING

Southwest Hospital affiliated to the Third Military Medical University

Chongqing, Chongqing Municipality, China

Site Status RECRUITING

ShanXi Traditional Medicine Hospital

Taiyuan, Shanxi, China

Site Status RECRUITING

The Cancer Hospital affiliated to Tianjin Medical University

Tianjin, Tianjin Municipality, China

Site Status RECRUITING

Chifeng Baoshan Hospital

Chifeng, , China

Site Status RECRUITING

First Affiliated Hospital of Chongqing Medical University

Chongqing, , China

Site Status RECRUITING

First People's Hospital of Honghe State

Mengzi, , China

Site Status RECRUITING

Ordos Central Hospital

Ordos, , China

Site Status RECRUITING

Qingdao Municipal Hospital

Qingdao, , China

Site Status RECRUITING

First Affiliated Hospital of China Medical University

Shenyang, , China

Site Status RECRUITING

Hospital of Xinjiang Production and Construction Corps

Ürümqi, , China

Site Status RECRUITING

Third Hospital of Xingtai

Xingtai, , China

Site Status RECRUITING

Yingshan Maternal and Child Health Hospital

Yingshan, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sun Qiang, MD

Role: CONTACT

86-010-69152701

Shen Songjie, MD

Role: CONTACT

86-010-69152701

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sun Qiang, Doctor

Role: primary

86-010-69152701

Shen Songjie, Doctor

Role: backup

86-010-69152701

Hongchuan Jiang, MD

Role: primary

Bo Li, MD

Role: primary

Yinhua Liu, MD

Role: primary

Jun Jiang, MD

Role: primary

Yue Shi, MD

Role: primary

Jin Zhang, MD

Role: primary

Yaping Li, MD

Role: primary

Guosheng Ren, MD

Role: primary

Fengming Xie, MD

Role: primary

Zhendong Wang, MD

Role: primary

Mei Sun, MD

Role: primary

Feng Jin, MD

Role: primary

Shuanghu Yuan, MD

Role: primary

Jingjing Yu, MD

Role: primary

Yue Chen, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PUMCH-breast-screening 2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.